Publicaciones en colaboración con investigadores/as de Thomas Jefferson University (13)

2024

  1. Clinical relevance of intracranial hemorrhage after thrombectomy versus medical management for large core infarct: a secondary analysis of the SELECT2 randomized trial

    Journal of NeuroInterventional Surgery, pp. 1-8

  2. Predictors of anastomotic leak and conduit necrosis after oesophagectomy: Results from the oesophago-gastric anastomosis audit (OGAA)

    European Journal of Surgical Oncology, Vol. 50, Núm. 6

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Mortality from esophagectomy for esophageal cancer across low, middle, and high-income countries: An international cohort study

    European Journal of Surgical Oncology, Vol. 47, Núm. 6, pp. 1481-1488

  3. Quality of Life Effect of the Anti-CCR4 Monoclonal Antibody Mogamulizumab Versus Vorinostat in Patients With Cutaneous T-cell Lymphoma

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 2, pp. 97-105

  4. SELECTion criteria for large core trials: Dogma or data?

    Journal of NeuroInterventional Surgery

2018

  1. Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

    The Lancet Oncology, Vol. 19, Núm. 9, pp. 1192-1204

2017

  1. Responses to romidepsin by line of therapy in patients with relapsed or refractory peripheral T-cell lymphoma

    Cancer Medicine, Vol. 6, Núm. 1, pp. 36-44

2015

  1. Utility of 18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma

    Annals of Oncology, Vol. 26, Núm. 4, pp. 774-779

2014

  1. Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma

    Biomarker Research, Vol. 2, Núm. 1

2002

  1. Elevated JNK activation contributes to the pathogenesis of human brain tumors

    Oncogene, Vol. 21, Núm. 33, pp. 5038-5046

  2. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors

    American Journal of Pathology, Vol. 160, Núm. 2, pp. 441-447

1995

  1. Frequent Expression of a Mutant Epidermal Growth Factor Receptor in Multiple Human Tumors

    Cancer Research, Vol. 55, Núm. 23, pp. 5536-5539